Tumour necrosis factor alpha and interleukin 10 gene polymorphisms and the risk of ischemic stroke in south Indian population

Journal of Genetics

Volumn 90, Issue 2, 2011, Pages 361-364

  Sultana, Shehnaz ^a,c   Kolla, Venkata K ^b   Jeedigunta, Yasovanthi ^b   Penagaluru, Pranay K ^a   Joshi, Sindhu ^a   Rani, P Usha ^b   Reddy, P P ^a,c  

^a Bhagwan Mahavir Medical Research Centre   (India)

^b OSMANIA UNIVERSITY   (India)

^c School of Human Genome Research and Genetic Disorders   (India)

Author keywords

gene polymorphisms; interleukin 10; ischemic stroke; south Indian population; tumour necrosis factor alpha

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; INDIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

ADULT; AGED; BRAIN ISCHEMIA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; INTERLEUKIN-10; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053130368     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-011-0079-5     Document Type: Article

References (24)

1. Achal S. A., Ludmila P., Charles E. McCulloch, Trudy Poon K. Y., Connie H., Jonathan G. Z. et al. 2006 Tumor necrosis factor-α -238G> A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke37, 231-234.
2. Anand K., Chowdhury D., Singh K. B., Pandav C. S. and Kapoor S. K. 2001 Estimation of mortality and morbidity due to strokes in India. Neuroepidemiology20, 208-211.
3. Banerjee I., Gupta V., Ahmed T., Faizaan M., Agarwal P. and Ganesh S. 2008 Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res. Bull. 75, 158-165.
4. Bevan S. and Markus H. 2004 The genetics of stroke. ACNR4, 8-11.
5. Bis J. C., Heckbert S. R., Smith N. L., Reiner A. P., Rice K., Lumley T. et al. 2008 Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis198, 166-173.
6. Bonita R., Mendis S., Truelsen T., Bogousslavsky J., Toole J. and Yatsu F. 2004 The global stroke initiative. Lancet Neurol. 3, 391-393.
7. Byung-Cheol Lee, Se-Young Ahn, Ho-Kyung Doo, Sung-Vin Yim, Hee-Jae Lee, Sheng- Yu Jin et al. 2004 Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-α genes, but not the interleukin-1β gene. Neurosci. Lett. 357, 33-36.
8. Catto A. J., Kohler H. P., Bannan S., Stickland M., Carter A. and Grant P. J. 1998 Factor XIII val 34 leu: a novel association with primary intracerebral hemorrhage. Stroke29, 813-816.
9. Diagnosis and Classification of Diabetes Mellitus 2009 Definition and description of diabetes mellitus. 2009. Diabetes Care. 32, S62-S67.
10. Hoppe C., Klitz W., D'Harlingue K., Cheng S., Grow M., Steiner L. et al. 2007 Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke38, 2241-2246.
11. Karahan Z. C., Deda G., Sipahi T., Elhan A. H. and Akar N. 2005 TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb. Res. 115, 393-398.
12. Koch W., Kastrati A., Bottiger C., Mehilli J., von Beckerath N. and Schomig A. 2001 Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis159, 137-144.
13. Kolla Venkata K., Madhavi G., Pulla Reddy B., Srikanth Babu B. M. V., Yashovanthi J., Vijaya Lakshmi V. et al. 2009 Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine47, 173-177.
14. Lahari D. K., Steve Bye, Nurenberger Jr J. J., Mario E., Hondes D. and Crisp M. 1992 A non organic and non enzymatic extraction methods gives high yields of genomic DNA from whole blood samples than do nine other methods tested. J. Biochem. Biophys Methods25, 193-205.
15. Louis R., Leyder E., Malaise M., Bartsch P. and Louis E. 2000 Lack of association between adult asthma and the tumour necrosis factor alpha -308 polymorphism gene. Eur. Respir. J. 16, 604-608.
16. Meschia J. F. 2002 Subtyping in ischemic stroke genetic research. J. Stroke Cerebrovasc. Dis. 11, 208-219.
17. Munshi A., Rajeshwar K., Subhash Kaul, Amal Al-Hazzani, Ali A. Alshatwi et al. 2010 Interleukin-10-1082 promoter polymorphism and ischemic stroke risk in a South Indian population. Cytokine52, 221-224.
18. O'Donell H. C., Rosand J., Knudsen K. A., Furie K. L., Segal A. Z., Chiu R. et al. 2000 Apolipoprotein E genotype and the risk of recurrent lobar intra cerebral hemorrhage. N. Engl. J. Med. 342, 240-245.
19. Pawlikowska L., Tran M. N., Achrol A. S., Mc Culloch C. E., Ha C., Lind D. L. et al. 2004 Polymorphisms in genes in inflammatory and Angiogenic pathways and the risk of hemorrhagic presentation of brain arterioveinous malformations. Stroke35, 2294-2300.
20. Perrey C., Turner S. J., Pravica V., Howell W. M. and Hutchinson I. V. 1999 ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta1 gene polymorphisms. Transplant. Immunol. 7, 127-128.
21. Rastenyte D., Tuomilehto J. and Sarti C. 1998 Genetics of stroke: a review. J. Neurol. Sci. 153, 132-145.
22. Ross R. 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature362, 801-809.
23. Tong Y., Geng Y., Xu J., Wang Z., Zhang Y., Lin L. et al. 2010 The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: two case-control studies. Clin. Chim. Acta. 411, 1291-1295.
24. 2 test. Suppl. J. R. Stat. Soc. 2, 217-235.